Future, Facts, and Fears on Pharmaceutical & Biotech Outsourcing, More at Annual Forum, July 11-12 in Atlantic City

NEW YORK, June 27  /PRNewswire/ -- International Institute for Business Information & Growth LLC (iiBIG) presents the Pharmaceutical & Biotech Outsourcing forum, on July 11-12, 2007, in Atlantic City. Top executives from global pharma, biotech and service provider companies from Germany, India, Canada, Italy, U.K., and the U.S., attending will review the state of the industry regarding outsourcing "From Discovery to IND" (Investigational New Drug Applications). Key plenary sessions this year include a co-presentation on "New Drug Discovery and Development - Outsourcing in the Developing World" to be given by Shang-Ying Peter King, PhD, Vice President, Global DMPK at Quest Pharmaceutical Services and Ahsan A. Awan JD, MBA, Chief Executive Officer for Global CINRG and an opening keynote address on "Outsourcing Outlook 2010:  Facts, Factors, and the Future" to be delivered by Christopher- Paul Milne, D.V.M., M.P.H., J.D, Associate Director for Tufts Center for Drug Development, Tufts University School of Medicine.

Another special feature of this year's event includes a roundtable "meet and greet" networking luncheon for the speaking faculty and attendees, scheduled for the first day of the conference.

Partial attendee list includes scientists and executives from Abbott Laboratories, Novartis, F.Hoffmann-La Roche, Wyeth Research, sanofi-aventis, Merck, BASF, GPC Biotech, Boehringer Ingelheim, MPI Research, Evotec Inc., Asterand, plc., NiKem Research, Rheoscience A/S, Charles River Laboratories, Dalton Pharmaceuticals, and more.

Attendees will get the latest industry updates and trends in outsourcing and be exposed to available networking opportunities. The forum presents over 40 executive-level speaking faculty members covering 2 in-depth tracks and case studies on early stage outsourcing.

  -- TRACK 1: covers the Stages of Development -- from early Molecule
     Screening to Phase I Clinical Trials.
     This track offers in-depth coverage on screening, pharmacology, drug
     discovery chemistry, ADME, formulations and more up to Phase I

  -- TRACK 2: covers the Process of Outsourcing -- practical tips and real-
     world examples on how to insure that outsourcing partnerships run
     smoothly. This track will focus on business and strategy process issues
     such as negotiating tips, relationship management, intellectual
     property, e-collaboration, and the unique consideration involved in
     cross-cultural outsourcing partnerships.



For complete conference details and registration information, visit: http://www.iibig.com/P0702 

International Institute for Business Information & Growth LLC


CONTACT:  Don Buford, Chief Executive Officer of International Institute
for Business Information & Growth LLC (iiBIG), +1-212-300-2521,
donb@iibig.com



Web site:  http://www.iibig.com/
http://www.iibig.com/P0702

</block>